199 related articles for article (PubMed ID: 22696672)
1. Persistent oseltamivir-resistant pandemic influenza A/H1N1 infection in an adult with cystic fibrosis.
Flight WG; Bright-Thomas R; Mutton K; Webb K; Jones A
BMJ Case Rep; 2011 Apr; 2011():. PubMed ID: 22696672
[TBL] [Abstract][Full Text] [Related]
2. Oseltamivir-induced resistant pandemic A/H1N1 influenza virus in a child with cystic fibrosis and Pseudomonas aeruginosa infection.
Esposito S; Molteni CG; Colombo C; Daleno C; Daccò V; Lackenby A; Principi N
J Clin Virol; 2010 May; 48(1):62-5. PubMed ID: 20335065
[TBL] [Abstract][Full Text] [Related]
3. Lessons from a French collaborative case-control study in cystic fibrosis patients during the 2009 A/H1N1 influenza pandemy.
Bucher J; Boelle PY; Hubert D; Lebourgeois M; Stremler N; Durieu I; Bremont F; Deneuville E; Delaisi B; Corvol H; Bassinet L; Grenet D; Remus N; Vodoff MV; Boussaud V; Troussier F; Leruez-Ville M; Treluyer JM; Launay O; Sermet-Gaudelus I
BMC Infect Dis; 2016 Feb; 16():55. PubMed ID: 26830335
[TBL] [Abstract][Full Text] [Related]
4. Treatment of resistant influenza virus infection in a hospitalized patient with cystic fibrosis with DAS181, a host-directed antiviral.
Silveira FP; Abdel-Massih R; Bogdanovich T; Pakstis DL; Routh RL; Moss RB
Antivir Ther; 2016; 21(1):71-4. PubMed ID: 26133231
[TBL] [Abstract][Full Text] [Related]
5. Persistence of pandemic influenza H1N1 virus in young patients after oseltamivir therapy in the 2009-2010 season: a comparison with seasonal H1N1 with or without H275Y mutation.
Kawai N; Ikematsu H; Iwaki N; Kondou K; Hirotsu N; Kawashima T; Maeda T; Tanaka O; Doniwa K; Iwakuni O; Egashira K; Yamaji K; Kashiwagi S
J Infect Chemother; 2012 Apr; 18(2):180-6. PubMed ID: 22193710
[TBL] [Abstract][Full Text] [Related]
6. Oseltamivir-resistant pandemic A(H1N1) 2009 influenza viruses detected through enhanced surveillance in the Netherlands, 2009-2010.
Meijer A; Jonges M; Abbink F; Ang W; van Beek J; Beersma M; Bloembergen P; Boucher C; Claas E; Donker G; van Gageldonk-Lafeber R; Isken L; de Jong A; Kroes A; Leenders S; van der Lubben M; Mascini E; Niesters B; Oosterheert JJ; Osterhaus A; Riesmeijer R; Riezebos-Brilman A; Schutten M; Sebens F; Stelma F; Swaan C; Timen A; van 't Veen A; van der Vries E; te Wierik M; Koopmans M
Antiviral Res; 2011 Oct; 92(1):81-9. PubMed ID: 21767571
[TBL] [Abstract][Full Text] [Related]
7. Emergence of oseltamivir resistance: control and management of influenza before, during and after the pandemic.
Dixit R; Khandaker G; Ilgoutz S; Rashid H; Booy R
Infect Disord Drug Targets; 2013 Feb; 13(1):34-45. PubMed ID: 23675925
[TBL] [Abstract][Full Text] [Related]
8. Frequency of oseltamivir resistance in Sydney, during the Newcastle outbreak of community transmitted oseltamivir-resistant influenza A(H1N1)pdm09 virus, Australia, June to August 2011.
Wang B; Taylor J; Ratnamohan M; McPhie K; Kesson A; Dixit R; Booy R; Hurt A; Saksena N; Dwyer DE
Euro Surveill; 2012 Jul; 17(27):. PubMed ID: 22790606
[TBL] [Abstract][Full Text] [Related]
9. Oseltamivir-resistant pandemic (H1N1) 2009 influenza in a severely ill patient: the first Australian case.
Speers DJ; Williams SH; Pinder M; Moody HR; Hurt AC; Smith DW
Med J Aust; 2010 Feb; 192(3):166-8. PubMed ID: 20121687
[TBL] [Abstract][Full Text] [Related]
10. Detection of the rapid emergence of the H275Y mutation associated with oseltamivir resistance in severe pandemic influenza virus A/H1N1 09 infections.
Wang B; Dwyer DE; Blyth CC; Soedjono M; Shi H; Kesson A; Ratnamohan M; McPhie K; Cunningham AL; Saksena NK
Antiviral Res; 2010 Jul; 87(1):16-21. PubMed ID: 20385168
[TBL] [Abstract][Full Text] [Related]
11. Oseltamivir-resistant pandemic (H1N1) 2009 virus infections, United States, 2010-11.
Storms AD; Gubareva LV; Su S; Wheeling JT; Okomo-Adhiambo M; Pan CY; Reisdorf E; St George K; Myers R; Wotton JT; Robinson S; Leader B; Thompson M; Shannon M; Klimov A; Fry AM;
Emerg Infect Dis; 2012 Feb; 18(2):308-11. PubMed ID: 22305467
[TBL] [Abstract][Full Text] [Related]
12. Oseltamivir-resistant novel influenza A (H1N1) virus infection in two immunosuppressed patients - Seattle, Washington, 2009.
Centers for Disease Control and Prevention (CDC)
MMWR Morb Mortal Wkly Rep; 2009 Aug; 58(32):893-6. PubMed ID: 19696719
[TBL] [Abstract][Full Text] [Related]
13. Nosocomial outbreak of the pandemic Influenza A (H1N1) 2009 in critical hematologic patients during seasonal influenza 2010-2011: detection of oseltamivir resistant variant viruses.
Pollara CP; Piccinelli G; Rossi G; Cattaneo C; Perandin F; Corbellini S; Tomasi DD; Bonfanti C
BMC Infect Dis; 2013 Mar; 13():127. PubMed ID: 23496867
[TBL] [Abstract][Full Text] [Related]
14. [Fatal pneumonitis due to oseltamivir-resistant new influenza A(H1N1) in the case of an intensive care patient].
Aardema H; Tulleken JE; van den Biggelaar RJ; Wolters BA; de Jager CM; Boucher CA; Riezebos-Brilman A
Ned Tijdschr Geneeskd; 2010; 154():A1634. PubMed ID: 20482913
[TBL] [Abstract][Full Text] [Related]
15. Monitoring and characterization of oseltamivir-resistant pandemic (H1N1) 2009 virus, Japan, 2009-2010.
Ujike M; Ejima M; Anraku A; Shimabukuro K; Obuchi M; Kishida N; Hong X; Takashita E; Fujisaki S; Yamashita K; Horikawa H; Kato Y; Oguchi A; Fujita N; Tashiro M; Odagiri T;
Emerg Infect Dis; 2011 Mar; 17(3):470-9. PubMed ID: 21392439
[TBL] [Abstract][Full Text] [Related]
16. Oseltamivir-resistant influenza viruses circulating during the first year of the influenza A(H1N1) 2009 pandemic in the Asia-Pacific region, March 2009 to March 2010.
Hurt AC; Deng YM; Ernest J; Caldwell N; Leang L; Iannello P; Komadina N; Shaw R; Smith D; Dwyer DE; Tramontana AR; Lin RT; Freeman K; Kelso A; Barr IG
Euro Surveill; 2011 Jan; 16(3):. PubMed ID: 21262183
[TBL] [Abstract][Full Text] [Related]
17. [Current anti-influenza virus chemotherapy].
Yoshioka D; Tokimatsu I; Ishii H; Kadota J
Nihon Rinsho; 2010 Sep; 68(9):1679-84. PubMed ID: 20845747
[TBL] [Abstract][Full Text] [Related]
18. Factors promoting the prolonged shedding of the pandemic (H1N1) 2009 influenza virus in patients treated with oseltamivir for 5 days.
Ryoo SM; Kim WY; Sohn CH; Seo DW; Oh BJ; Lee JH; Lee YS; Lim KS
Influenza Other Respir Viruses; 2013 Sep; 7(5):833-7. PubMed ID: 23279949
[TBL] [Abstract][Full Text] [Related]
19. A two-year survey of the oseltamivir-resistant influenza A(H1N1) virus in Yamagata, Japan and the clinical effectiveness of oseltamivir and zanamivir.
Matsuzaki Y; Mizuta K; Aoki Y; Suto A; Abiko C; Sanjoh K; Sugawara K; Takashita E; Itagaki T; Katsushima Y; Ujike M; Obuchi M; Odagiri T; Tashiro M
Virol J; 2010 Mar; 7():53. PubMed ID: 20202225
[TBL] [Abstract][Full Text] [Related]
20. Oseltamivir-resistant influenza A 2009 H1N1 virus in immunocompromised patients.
Couturier BA; Bender JM; Schwarz MA; Pavia AT; Hanson KE; She RC
Influenza Other Respir Viruses; 2010 Jul; 4(4):199-204. PubMed ID: 20836794
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
